FOLFIRINOX regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords:Fluorouracil/irinotecan/leucovorin calcium/oxaliplatin; Fluorouracil with Irinotecan Hydrochloride, Leucovorin Calcium and Oxaliplatin; Folfirinox Protocol; Folfirinox Regimen

Overview

FOLFIRINOX regimen refers to a regimen consisting of fluorouracil, irinotecan hydrochloride, leucovorin calcium and oxaliplatin used for the treatment of pancreatic cancer.^[1]^[2]

Regimen

FOLLeucovorin calcium (Folinic acid)

FIFluorouracil

RIIrinotecan hydrochloride

OXOxaliplatin

Indications

Pancreatic cancer^[2]

References

↑ “NCI Thesaurus”.
↑ ^2.0 ^2.1 Conroy T, Gavoille C, Samalin E, Ychou M, Ducreux M (2013). “The role of the FOLFIRINOX regimen for advanced pancreatic cancer”. Curr Oncol Rep. 15 (2): 182–9. doi:10.1007/s11912-012-0290-4. PMID 23341367.

[1] “NCI Thesaurus”.

[pmid23341367-2] 2.0 ^2.1 Conroy T, Gavoille C, Samalin E, Ychou M, Ducreux M (2013). “The role of the FOLFIRINOX regimen for advanced pancreatic cancer”. Curr Oncol Rep. 15 (2): 182–9. doi:10.1007/s11912-012-0290-4. PMID 23341367.

[1]

[2]